Quantinno Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Quantinno Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$91.1K	Buy	+14,596	New	+$63K	﹤0.01%	3393
2025 Q1	–	Sell	-67,424	Closed	-$367K	–	2129
2024 Q4	$367K	Sell	67,424 -269,103	-80%	-$1.73M	﹤0.01%	1328
2024 Q3	$2.8M	Buy	336,527 +289,141	+610%	+$2.5M	0.04%	604
2024 Q2	$339K	Buy	47,386 +7,084	+18%	+$61.2K	0.01%	1120
2024 Q1	$349K	Buy	40,302 +8,866	+28%	+$60K	0.01%	1043
2023 Q4	$206K	Buy	+31,436	New	+$203K	0.01%	1047

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Quantinno Capital Management's MRVI Position: Q2 2026 in Review

Quantinno Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 14,596 shares worth $91.1K. The stake represents ﹤0.01% of the portfolio and ranks #3393 among its holdings. This is a return to the name: Quantinno Capital Management previously reported a position in MRVI as recently as Q4 2024.

Quantinno Capital Management first reported a position in MRVI in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.8M in Q3 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Quantinno Capital Management held 14,596 shares of Maravai LifeSciences worth $91.1K as of Q2 2026.
Maravai LifeSciences was a new Quantinno Capital Management position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3393 holding.
Quantinno Capital Management first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 6 quarters since.
Quantinno Capital Management's Maravai LifeSciences position peaked at $2.8M in Q3 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.